Iyer, R. N., Favela, D., Zhang, G. & Olson, D. E. The iboga enigma: the chemistry and neuropharmacology of iboga alkaloids and related analogs. Nat. Prod. Rep. 38, 307–329 (2021).
Article CAS PubMed PubMed Central Google Scholar
Kock, P., Froelich, K., Walter, M., Lang, U. & Dursteler, K. M. A systematic literature review of clinical trials and therapeutic applications of ibogaine. J. Subst. Abuse Treat. 138, 108717 (2022).
Article CAS PubMed Google Scholar
Wasko, M. J., Witt-Enderby, P. A. & Surratt, C. K. DARK classics in chemical neuroscience: ibogaine. ACS Chem. Neurosci. 9, 2475–2483 (2018).
Article CAS PubMed Google Scholar
Belgers, M. et al. Ibogaine and addiction in the animal model, a systematic review and meta-analysis. Transl. Psychiatry 6, e826 (2016).
Article CAS PubMed PubMed Central Google Scholar
Koenig, X., Kovar, M., Boehm, S., Sandtner, W. & Hilber, K. Anti-addiction drug ibogaine inhibits hERG channels: a cardiac arrhythmia risk. Addict. Biol. 19, 237–239 (2014).
Article CAS PubMed Google Scholar
Thurner, P. et al. Mechanism of hERG channel block by the psychoactive indole alkaloid ibogaine. J. Pharmacol. Exp. Ther. 348, 346–358 (2014).
Alper, K. R., Stajić, M. & Gill, J. R. Fatalities temporally associated with the ingestion of ibogaine. J. Forensic Sci. 57, 398–412 (2012).
Article CAS PubMed Google Scholar
Koenig, X. & Hilber, K. The anti-addiction drug ibogaine and the heart: a delicate relation. Molecules 20, 2208–2228 (2015).
Article PubMed PubMed Central Google Scholar
Cameron, L. P. et al. A non-hallucinogenic psychedelic analogue with therapeutic potential. Nature 589, 474–479 (2021).
Article CAS PubMed Google Scholar
Glick, S. D., Kuehne, M. E., Maisonneuve, I. M., Bandarage, U. K. & Molinari, H. H. 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats. Brain Res. 719, 29–35 (1996).
Article CAS PubMed Google Scholar
Rocha, J. M., Reis, J. A. S., Buoso, J. C., Hallak, J. E. C. & Dos Santos, R. G. Identifying setting factors associated with improved ibogaine safety: a systematic review of clinical studies. Eur. Arch. Psychiatry Clin. Neurosci. 273, 1527–1542 (2023).
Cherian, K. N. et al. Magnesium-ibogaine therapy in veterans with traumatic brain injuries. Nat. Med. 30, 373–381 (2024).
Article CAS PubMed PubMed Central Google Scholar
Noeller, G. E., Frampton, C. M. & Yazar-Klosinski, B. Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study. Am. J. Drug Alcohol Abuse 44, 37–46 (2018).
Davis, A. K., Barsuglia, J. P., Windham-Herman, A., Lynch, M. & Polanco, M. Subjective effectiveness of ibogaine treatment for problematic opioid consumption: short- and long-term outcomes and current psychological functioning. J. Psychedelic Stud. 1, 65–73 (2017).
Article PubMed PubMed Central Google Scholar
Dickel, D. F., Holden, C. L., Maxfield, R. C., Paszek, L. & Taylor, W. The alkaloids of Tabernanthe iboga. Part III. Isolation studies. J. Am. Chem. Soc. 80, 123–125 (1958).
Jenks, C. W. Extraction studies of Tabernanthe iboga and Voacanga africana. Nat. Prod. Lett. 16, 71–76 (2002).
Article CAS PubMed Google Scholar
Gonzalez, B. et al. Efficient access to the iboga skeleton: optimized procedure to obtain voacangine from Voacanga africana root bark. ACS Omega 6, 16755–16762 (2021).
Article CAS PubMed PubMed Central Google Scholar
Farrow, S. C. et al. Biosynthesis of an anti-addiction agent from the iboga plant. J. Am. Chem. Soc. 141, 12979–12983 (2019).
Article CAS PubMed PubMed Central Google Scholar
Farrow, S. C. et al. Cytochrome P450 and O-methyltransferase catalyze the final steps in the biosynthesis of the anti-addictive alkaloid ibogaine from Tabernanthe iboga. J. Biol. Chem. 293, 13821–13833 (2018).
Article CAS PubMed PubMed Central Google Scholar
Trost, B. M., Godleski, S. A. & Genet, J. P. A total synthesis of racemic and optically active ibogamine. Utilization and mechanism of a new silver ion assisted palladium catalyzed cyclization. J. Am. Chem. Soc. 100, 3930–3931 (1978).
Imanishi, T., Yagi, N. & Hanaoka, M. 1,6-Dihydro-3(2H)-pyridinones. X. 2-Azabicyclo[2.2.2]octane ring formation via intramolecular Michael reaction: total synthesis of (±)-ibogamine and (±)-epiibogamine. Chem. Pharm. Bull. 33, 4202–4211 (1985).
Höck, S. & Borschberg, H. J. Enantioselective synthesis of (−)-(19R)-ibogamin-19-ol. Helv. Chim. Acta 89, 542–557 (2006).
Harada, M. et al. Asymmetric total synthesis of an iboga-type indole alkaloid, voacangalactone, newly isolated from Voacanga africana. Org. Lett. 14, 5800–5803 (2012).
Article CAS PubMed Google Scholar
Mizoguchi, H., Oikawa, H. & Oguri, H. Biogenetically inspired synthesis and skeletal diversification of indole alkaloids. Nat. Chem. 6, 57–64 (2013).
Kruegel, A. C., Rakshit, S., Li, X. & Sames, D. Constructing iboga alkaloids via C–H bond functionalization: examination of the direct and catalytic union of heteroarenes and isoquinuclidine Alkenes. J. Org. Chem. 80, 2062–2071 (2015).
Article CAS PubMed Google Scholar
Zhang, G. et al. Synthesis of tertiary amines through extrusive alkylation of carbamates. Org. Lett. 24, 6208–6212 (2022).
Article CAS PubMed PubMed Central Google Scholar
Hughes, A. J. & Townsend, S. D. Gram-scale total synthesis of (±)-ibogamine. Org. Lett. 25, 4567–4570 (2023).
Article CAS PubMed Google Scholar
Hughes, A. J. & Townsend, S. D. Total synthesis of tabernanthine and ibogaline: rapid access to nosyl tryptamines. Eur. J. Org. Chem. 27, e202400442 (2024).
Raucher, S. & Bray, B. L. Total synthesis of (±)-catharanthine. J. Org. Chem. 50, 3236–3237 (1985).
Herdeis, C. & Hartke-Karger, C. Short and stereoselective synthesis of (±)-ibogamine via a vinylsulfone intermediate, IV. Liebigs Ann. Chem. 2, 99–104 (1991).
Büchi, G., Coffen, D. L., Kocsis, K., Sonnet, P. E. & Ziegler, F. E. The total synthesis of iboga alkaloids. J. Am. Chem. Soc. 88, 3099–3109 (1966).
Jana, G. K. & Sinha, S. Total synthesis of ibogaine, epiibogaine and their analogues. Tetrahedron 68, 7155–7165 (2012).
Zhao, G. et al. Bioinspired collective syntheses of iboga-type indole alkaloids. Org. Lett. 18, 2447–2450 (2016).
Comments (0)